AI summary
Summary of article:
Although lung cancer is still the leading cause of cancer deaths in the United States, with advances in genetic testing, targeted therapy, and immunotherapy, patients’ chances of survival have improved significantly, and more attention is also being paid to non-smokers.
Every year November is observed as “Lung Cancer Awareness Month” in the United States.cancer Data released by the Research Association shows that lung cancer is still the leading cause of cancer deaths in the United States. However, with the continued advancement of medical technology, this once shameful disease is undergoing profound changes.
This issue of “New York Health 365” invites members of the Board of Directors of the Asian American Physicians Association.tumor Physician Dr. Liu Yuqing explains the major advances made in lung cancer, from early detection, genetic testing, to targeted therapy and immunotherapy, and how these breakthroughs change patients’ chances of survival.
Liu Yuqing recalled that when he was engaged in cancer treatment in his early years, the survival time of some patients with advanced lung cancer could often only be calculated in months. Today, as treatments continue to improve, more and more patients have the opportunity to live longer.
Behind these changes is a significant shift from the traditional model to precision and personalization in lung cancer treatment. Through genetic testing, doctors can identify specific gene mutations in the tumors of some lung cancer patients and select corresponding target drugs. The combination of immunotherapy, chemotherapy and surgery may also bring better therapeutic effects in some patients. This can significantly shrink the tumor before surgery and also reduce the risk of postoperative recurrence.
Also, the medical community is paying more attention to the increased risk of lung cancer in non-smokers, especially Asian women. Liu Yuqing pointed out that smoking is still the most important risk factor for lung cancer, but air pollution, radon gas exposure and genetic mutations may also be related to the incidence of lung cancer.
Who needs to pay special attention to those at risk for lung cancer, and how can they take advantage of the opportunity for early detection and treatment? Welcome to this issue of “New York Health 365” and listen to Dr. Liu Yuqing’s detailed explanation.
➤Spotify Podcast
➤Apple Podcast
Summary FAQ
-
The report notes that lung cancer treatment has moved away from the traditional model toward precision and personalization. By identifying mutations through genetic testing combined with targeted drugs, immunotherapy, chemotherapy, and surgery, treatment effects and survival times for many patients have been improved.
-
Early screening can help detect tumors early, and genetic testing can detect mutations that may respond to drugs, allowing doctors to choose more precise treatment options, reducing the risk of recurrence and increasing the chances of controlling the disease and living longer.
-
Smokers are still the highest risk group, but non-smokers, especially Asian women, cannot be ignored. In addition to smoking, air pollution, radon exposure and genetic mutations can increase the risk of lung cancer, so early screening should be emphasized.
